X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/25/2870046/32452/en/Adverum-Biotechnologies-to-Present-LUNA-26-week-Phase-2-Interim-Analysis-at-the-ASRS-Annual-Scientific-Meeting.html
https://www.globenewswire.com/news-release/2024/03/18/2848148/32452/en/Adverum-Biotechnologies-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Pipeline-Highlights-and-Corporate-Updates.html
https://www.globenewswire.com/news-release/2024/03/18/2848148/32452/en/Adverum-Biotechnologies-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Pipeline-Highlights-and-Corporate-Updates.html
https://www.globenewswire.com//news-release/2024/02/28/2837406/32452/en/Adverum-Biotechnologies-to-Participate-in-the-TD-Cowen-44th-Annual-Health-Care-Conference.html
https://www.globenewswire.com//news-release/2024/02/12/2827495/32452/en/Adverum-Biotechnologies-to-Participate-in-the-Oppenheimer-34th-Annual-Healthcare-Life-Sciences-Conference.html
https://www.globenewswire.com//news-release/2024/02/08/2825871/32452/en/Adverum-Biotechnologies-Announces-Positive-Preliminary-Efficacy-and-Safety-Data-from-LUNA-Phase-2-Trial-of-Ixo-vec-in-Patients-with-Wet-AMD.html
https://www.fiercebiotech.com/biotech/adverums-gene-therapy-shows-promise-wet-amd-ph-2-though-questions-remain
https://www.globenewswire.com//news-release/2024/02/05/2823441/32452/en/Adverum-Biotechnologies-Announces-127-5-Million-Private-Placement-Financing.html
https://www.globenewswire.com//news-release/2024/02/01/2822523/32452/en/Adverum-Biotechnologies-will-Host-Webcast-to-Review-LUNA-Phase-2-Preliminary-Efficacy-and-Safety-Results-on-February-8-2024.html
https://www.globenewswire.com/news-release/2024/01/29/2818844/32452/en/Adverum-Biotechnologies-Appoints-Romuald-Corbau-Ph-D-as-Chief-Scientific-Officer.html
Market Place
Share 
